Israeli Police Use First Bedouin Undercover Agent to Bust Nationwide Illegal Arms and Drug Network
In an unprecedented operation by the Israeli police unit Lahav 433, a Bedouin undercover agent known as "The Nomad" infiltrated criminal networks for over a year, leading to a major crackdown on illegal arms and drug trafficking across Israel. The agent successfully purchased four M16 rifles, dozens of handguns, and about half a kilogram of cocaine, meticulously documenting each transaction to build evidence against the suspects.
On Monday morning, hundreds of police officers, Border Police fighters, and special units raided dozens of locations in cities including Rahat, Tel Sheva, Bir al-Saba, Arad, Dimona, Eilat, and East Jerusalem. The raids resulted in the arrest of dozens of suspects, including 20 key figures involved in arms and drug trafficking. The operation was led by the Lahav 433 unit's Etgar division and its undercover agents department.
Police Commissioner Major General Danni Levi emphasized that the case demonstrates there is no safe haven for criminals from Israeli law enforcement. He praised the undercover agent's role and the coordinated efforts of Lahav 433 and partner units in preventing potentially deadly arms and drug deals. Lahav 433 Commander Commissioner Meni Benyamin highlighted the intelligence and operational complexity of the case, noting the significant blow dealt to criminal networks threatening public safety.
The arrested suspects are scheduled to appear in the Rishon Lezion Magistrate's Court later today for detention extension hearings. This operation marks a milestone in Israeli policing by integrating a Bedouin agent to penetrate deeply into Bedouin criminal circles, leveraging cultural familiarity to gain trust and gather critical evidence.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.